This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Jose Tinajero, PharmD, BCOP
Advertisement
Articles by Jose Tinajero, PharmD, BCOP
Delayed pegaspargase reduces hepatotoxicity without affecting outcomes.
Leukemia biology may predict patterns of blinatumomab failure after initial response.
The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.
A single-center experience at a tertiary medical center precision medicine clinic provides insight.
Pharmacists will play a significant role in TKI adherence rates among patients.
Advertisement
Latest Updated Articles
A Step Forward: Optimizing the Delivery of Pegaspargase Therapy in Adult Patients With ALLPublished: April 21st 2025 | Updated:
Predictors of Blinatumomab Therapy Failure and CD19-Negative Relapse in Adult B-Cell ALLPublished: January 30th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Incidence of Invasive Fungal Infections Following BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
3
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
4
New Study Evaluates Neoadjuvant HER3-Targeted ADC in Early Triple-Negative Breast Cancer
5
